IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MEOLA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.959
NA - Nord America 16.687
AS - Asia 12.277
SA - Sud America 1.289
AF - Africa 212
OC - Oceania 121
Continente sconosciuto - Info sul continente non disponibili 7
Totale 47.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.002
GB - Regno Unito 5.143
IT - Italia 4.015
CN - Cina 3.650
SG - Singapore 3.428
DE - Germania 1.593
RU - Federazione Russa 1.250
SE - Svezia 1.102
HK - Hong Kong 1.025
BR - Brasile 869
FR - Francia 840
VN - Vietnam 767
BD - Bangladesh 753
IN - India 622
TR - Turchia 577
UA - Ucraina 574
NL - Olanda 554
CA - Canada 508
KR - Corea 489
IE - Irlanda 471
FI - Finlandia 459
EU - Europa 304
JP - Giappone 300
ID - Indonesia 206
CO - Colombia 194
ES - Italia 188
PL - Polonia 114
BE - Belgio 104
AU - Australia 102
MX - Messico 99
GR - Grecia 98
AR - Argentina 73
CH - Svizzera 62
PT - Portogallo 59
DK - Danimarca 55
PH - Filippine 55
IQ - Iraq 54
TW - Taiwan 50
RO - Romania 46
ZA - Sudafrica 43
CZ - Repubblica Ceca 42
EC - Ecuador 39
AT - Austria 38
PK - Pakistan 37
CI - Costa d'Avorio 35
MY - Malesia 35
CL - Cile 34
EG - Egitto 31
NO - Norvegia 31
UZ - Uzbekistan 30
VE - Venezuela 27
IR - Iran 25
PE - Perù 24
IL - Israele 23
HU - Ungheria 22
SA - Arabia Saudita 22
TN - Tunisia 21
RS - Serbia 19
KE - Kenya 18
PY - Paraguay 18
BG - Bulgaria 16
NZ - Nuova Zelanda 16
AE - Emirati Arabi Uniti 15
TH - Thailandia 15
JM - Giamaica 13
JO - Giordania 13
CR - Costa Rica 12
DZ - Algeria 12
KZ - Kazakistan 11
SI - Slovenia 11
AZ - Azerbaigian 10
HR - Croazia 10
MA - Marocco 10
TT - Trinidad e Tobago 10
HN - Honduras 9
NP - Nepal 9
LU - Lussemburgo 8
AL - Albania 7
BY - Bielorussia 7
BJ - Benin 6
BO - Bolivia 6
LB - Libano 6
OM - Oman 6
QA - Qatar 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GT - Guatemala 5
PA - Panama 5
SN - Senegal 5
UY - Uruguay 5
AM - Armenia 4
CY - Cipro 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
PS - Palestinian Territory 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
Totale 47.782
Salva come PNG Salva come JPEG
Città #
Southend 4.474
Singapore 1.845
Ashburn 1.344
Chandler 1.120
Seattle 975
Hong Kong 952
Milan 950
San Jose 833
Beijing 714
Fairfield 662
Princeton 656
Wilmington 617
Council Bluffs 502
Dublin 458
Dallas 414
Jacksonville 398
Woodbridge 396
Dearborn 378
Santa Clara 372
Los Angeles 330
Mountain View 326
Houston 323
Ann Arbor 317
Redmond 307
Cambridge 270
Bengaluru 269
Rome 261
Nanjing 254
Lauterbourg 234
Redwood City 225
Somerville 223
Ho Chi Minh City 221
Toronto 221
Serra 208
New York 198
Boardman 190
Sakarya 190
Guangzhou 181
Hanoi 178
Hefei 177
Helsinki 174
Buffalo 173
Des Moines 168
Frankfurt am Main 167
Bogotá 162
Moscow 162
Andover 158
Shanghai 143
The Dalles 126
Columbus 119
Tokyo 118
Jakarta 117
Pisa 112
Phoenix 99
Hamburg 96
Jinan 95
Shenyang 93
Eitensheim 90
Athens 88
Cangzhou 86
Nanchang 80
Warsaw 80
Berlin 77
Seoul 77
São Paulo 77
London 72
Sunnyvale 68
Tianjin 68
Ottawa 64
Turin 62
Changsha 61
Medford 61
Bologna 60
Chicago 60
Munich 60
Naples 56
Brussels 55
Shenzhen 55
Hanover 53
Hebei 53
San Diego 50
Vigo 49
Grafing 46
Bitonto 44
Florence 43
Hangzhou 42
Washington 41
Falls Church 39
Boston 38
Dong Ket 37
Jiaxing 36
Abidjan 35
Nuremberg 35
Odernheim 35
Norwalk 34
Taipei 33
Atlanta 32
Bari 32
Montreal 32
Da Nang 31
Totale 27.772
Salva come PNG Salva come JPEG
Nome #
The progression of Muscular Impairment Rating Scale (MIRS) and the development of cardiac conduction abnormalities in DM1 699
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 654
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 598
Cerebral involvement in myotonic dystrophies 564
Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1 528
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 525
Increased visceral adipose tissue rather than BMI as a risk factor for dementia 474
Andersen's syndrome : a distinct periodic paralysis 467
DM1, DM2 e paralisi periodiche : diagnosi e terapia 458
Atipica presentazione di sclerosi multipla alla RMN : un caso di difficile diagnosi differenziale 443
Cognitive impairment in adult myotonic dystrophies : a longitudinal study 441
La canalopatia del cloro : diagnosi clinica differenziale 394
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 393
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 371
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 358
Treatment for periodic paralysis 353
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 337
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 330
Tolerability and safety of mexiletine in patients with myotonia dystrophy type 1 over time 321
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 314
Electromechanical delay components during skeletal muscle contraction and relaxation : novel physiological insights and possible application in Myotonic Dystrophies 311
A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature 303
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 300
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient 297
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 295
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 293
Deregulated MicroRNAs in Myotonic Dystrophy Type 2 285
Clinical factors associated with statins prescription in acute ischemic stroke patients : findings from the Lombardia Stroke Registry 282
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy 276
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 271
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 270
Therapy in myotonic disorders and in muscle channelopathies 268
Mexiletine Improves Symptoms and Signs of Myotonia in Non-dystrophic Myotonia 268
Circulating irisn is reduced in male patients with type 1 and type 2 Myotonic Dystrophies 266
"I know that you know that I know" : Neural substrates associated with social cognition deficits in DM1 patients 263
Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis 262
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect 260
High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy : A case-control study 260
RNA transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia : the ultrastructural evidence 258
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 256
Status update and interim results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2) 255
Bimodal administration of entacapone in Parkinson's disease patients improves motor control 252
A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies 252
Persistent autobiographical amnesia: a case report 247
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 247
Oculopharyngeal muscular dystrophy in Italy. 240
Studio longitudinale del coinvolgimento muscolare e cardiaco nella Distrofia Miotonica di tipo 1 (DM1) e di tipo 2 (DM2) 238
Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family 235
The role of clinical and neuroimaging features in the diagnosis of CADASIL 235
Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis 233
Amyotrophic lateral sclerosis presenting during pregnancy : report of clinical and genetic features of three cases 233
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 233
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods : a useful tool in myotonic dystrophy type 1 233
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 232
Muscle cramps, insuline resistance, acanthosis nigricans and acral hypertrphy sindrome : a potentially treatable condition 229
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2 229
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis 226
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 225
Endocrine alterations in myotonic dystrophy type 1 and type 2 : correlation with markers of muscle fiber atrophy 222
Lezioni di Traumatologia 220
Myotonia permanens with neonatal onset associated with a p.Gly1306Glu mutation in the SCN4A gene. 220
Consensus-based care recommendations for adults with myotonic dystrophy type 1. 219
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 218
Redefining clinical phenotype in a large color of Italian non-dystrophic myotonic patients. 218
Pathogenic role of ribonuclear inclusions in myotonic dystrophy type 2: myth or reality? 215
A CASE OF MITOCHONDRIAL MYOPATHY, LACTIC-ACIDOSIS AND COMPLEX-I DEFICIENCY 215
Cerebrospinal fluid (CSF) tau and amyloid beta42 (A beta 42) protein abnormalities correlate with executive dysfunction in myotonic dystrophy type 1 (DM1) and type 2 (DM2) 214
Plasma microRNAs as biomarkers for myotonic dystrophy type 1 214
Biomolecular diagnosis of myotonic dystrophy type 2 : a challenging approach 212
Clinical Reasoning : a 35-year-old woman with hyperstartling, stiffness, and accidental falls : a startling diagnosis 210
Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1 209
Myotonic dystrophies : state of the art of new therapeutic developments for the CNS 208
Computerized tomography and magnetic resonance muscle imaging in Miyoshi's myopathy 207
Quantitative myotonia assessment: an experimental protocol 206
Abnormalities of proliferative and differentiative properties in DM1 and DM2 senescence myoblasts -in vitro- 205
Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy 205
Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2 201
Rare Disease : Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 201
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1(DM-1) and in proximal myotonic myopathy (PROMM/DM-2) 196
Electrophysiology study protocol of arrhythmias in myotonic dystrophy type 1 and type 2 196
New mutations in SCN4A and their biophysical properties 195
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies 195
Gene expression analysis in Myotonic Dystrophy : indications for a common molecular pathogenic pathway in DM1 and DM2 193
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies 190
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2 189
A clinical, genetic and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia 186
Human skeletal muscle sodium channelopathies 185
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 185
Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia 185
A multidisciplinary approach improves quality of life perception in patients with amyotrophic lateral sclerosis 184
High prevalence of vitamin D deficiency in myotonic dystrophies 184
Migraine and patent foramen ovale: improvement after transcatheteral closure 183
Acetazolamide prevents vacuolar myopathy in skeletal muascle of K+ -depleted rats 183
Cerebrospinal fluid (CSF) Tau and amyloid Beta42 (AB42) protein abnormalities correlate with executive dysfuction in Myotonic Dystrophy Type 1 (DM1) and Type 2 (DM2) 183
RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2 : an immunocytochemical study 183
Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism 182
Guidelines on clinical presentation and management of nondystrophic myotonias 182
Unusual diagnostic and management problems in neuromuscular disease : Gitelman Syndrome 180
Muscle surface mechanical and electrical activities in myotonic dystrophy 180
Neuroimaging in the early diagnosis of Krabbe leukodystrophy types 1 and 2 179
Totale 27.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.278 268 126 211 121 238 283 293 135 312 371 276 644
2022/20233.956 568 331 369 463 463 697 141 242 366 73 150 93
2023/20242.362 99 189 148 98 509 177 85 150 75 221 246 365
2024/20255.613 280 612 143 441 393 252 257 636 314 511 572 1.202
2025/202612.347 1.112 770 1.308 849 1.051 884 1.348 771 1.287 993 1.140 834
2026/2027453 453 0 0 0 0 0 0 0 0 0 0 0
Totale 49.894